688617 惠泰医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)17.40029.28230.43529.09320.219
总资产报酬率 ROA (%)14.78124.74624.24222.25216.891
投入资产回报率 ROIC (%)16.91528.58529.11827.32619.242

边际利润分析
销售毛利率 (%)72.97772.87772.31371.26671.204
营业利润率 (%)39.57636.55536.48436.38432.647
息税前利润/营业总收入 (%)40.22435.98335.50435.94232.273
净利润/营业总收入 (%)34.58331.26031.86031.64027.973

收益指标分析
经营活动净收益/利润总额(%)96.07497.39197.42989.58394.164
价值变动净收益/利润总额(%)3.3331.8611.7663.8795.338
营业外收支净额/利润总额(%)-0.142-0.883-1.035-0.679-0.470

偿债能力分析
流动比率 (X)4.6724.6243.9822.9863.781
速动比率 (X)3.5473.5522.9992.4282.961
资产负债率 (%)13.78714.28114.28723.74619.538
带息债务/全部投入资本 (%)1.2520.5511.5725.7414.105
股东权益/带息债务 (%)7,731.65817,698.7706,212.1551,622.8042,308.037
股东权益/负债合计 (%)618.843592.258590.892312.144405.440
利息保障倍数 (X)57.139-142.856-58.513-182.126-145.934

营运能力分析
应收账款周转天数 (天)9.10211.25110.8669.66112.014
存货周转天数 (天)214.855228.909228.878252.775309.035